Clinical Trials Browser

Phase 2 × Paraganglioma × talazoparib × Clear all

NCT05142241 2025-11-18

Testing the Combination of Anti-Cancer Drugs Talazoparib and Temozolomide in Patients With Advanced Stage Rare Cancers, RARE 2 Trial

Phase 2 Active not recruiting

Paraganglioma, Pheochromocytoma